What is the recommended dosage of Etomidate during RSI induction?

The appropriate dosage of Etomidate during rapid sequence induction (RSI) is typically around 0.3 mg/kg. This dosage has been established through clinical practice as effective for providing rapid sedation without the significant cardiovascular depression that higher doses might cause. Etomidate is an ultra-short-acting anesthetic, and this specific dosage is sufficient to achieve the desired effect of inducing anesthesia while minimizing potential side effects.

Utilizing this recommended dose ensures that the patient is adequately sedated for intubation while maintaining hemodynamic stability, which is particularly important in critical care scenarios where patients may have compromised cardiovascular function. Therefore, a dose of 0.3 mg/kg is both effective for achieving the necessary level of sedation and safe for patient management during RSI.